Sean Bohen, Olema Oncology CEO
After refuting a supposed data leak as 'falsified', Olema reveals first clinical data for lead program — shares crash
Olema Oncology had been preparing to present the first clinical data from its lead program at a conference next week, but the biotech’s poster supposedly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.